Exactly. However, in the Alpha article this morning it mentions that a 1:2 - 1:10 was approved. That can be easily misconstrued if someone hasn't read yesterday's article that quotes Dr. Smith as saying a R/S is not under consideration at this time. So, regardless if someone thinks it's both idiotic or redundant, this continues to be a worry for the uninformed. That said, this is a fantastic company with great promise, and I am about to meet with a venture capitalist friend right now, to discuss, if he'll hear me out.